Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 7Uterine Cervical Neoplasms 5Neoplasms 4Esophageal Neoplasms 4Brain Neoplasms 4Thyroid Neoplasms 3Neuroendocrine Tumors 3Cholangiocarcinoma 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Urinary Bladder Neoplasms 2Unspecified Adult Solid Tumor, Protocol Specific 2Testicular Neoplasms 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Salivary Gland Neoplasms 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Multiple Myeloma 2Melanoma 2Lung Neoplasms 2Hematologic Neoplasms 2Glioblastoma 2Carcinoma, Transitional Cell 2Astrocytoma 2Adrenal Gland Neoplasms 2Vaginal Neoplasms 1Uveal Melanoma 1Uterine Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 4Temozolomide 3Surgical Procedures, Operative 3trametinib 2Magnetic Resonance Imaging 2Irinotecan 2Bortezomib 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2temsirolimus 1sonidegib 1ribociclib 1gallium Ga 68 dotatate 1fluoromisonidazole 1entinostat 1emvododstat 1carboxyamido-triazole 1avelumab 1aldesleukin 1Vorinostat 1Verteporfin 1Topotecan 1Thalidomide 1Surveys and Questionnaires 1Sodium Chloride 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiosurgery 1Proton Therapy 1Pioglitazone 1Photochemotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Meningioma × Fluorodeoxyglucose F18 × Clear all
NCT01246869 2024-10-01

Assessment of Primary and Metastatic Brain Tumor Hypoxia With Fluoromisonidazole, FDG and Water

University of Utah

Phase 1 Terminated
2 enrolled
CNS

Brain Neoplasms, Glioblastoma, Glioma, Meningioma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡